Jonathan S. Rink

765 total citations
29 papers, 617 citations indexed

About

Jonathan S. Rink is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, Jonathan S. Rink has authored 29 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 14 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Jonathan S. Rink's work include Cancer, Lipids, and Metabolism (12 papers), Ferroptosis and cancer prognosis (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Jonathan S. Rink is often cited by papers focused on Cancer, Lipids, and Metabolism (12 papers), Ferroptosis and cancer prognosis (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Jonathan S. Rink collaborates with scholars based in United States, United Kingdom and Singapore. Jonathan S. Rink's co-authors include C. Shad Thaxton, David P. Cormode, Pratap C. Naha, Leo I. Gordon, Kaylin M. McMahon, Sushant Tripathy, Shuo Yang, Xiaojuan Chen, Dixon B. Kaufman and Vinayak P. Dravid and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jonathan S. Rink

29 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan S. Rink United States 13 249 184 181 157 111 29 617
Bai Ji China 12 273 1.1× 111 0.6× 154 0.9× 215 1.4× 56 0.5× 36 618
Kaylin M. McMahon United States 17 581 2.3× 313 1.7× 194 1.1× 195 1.2× 150 1.4× 26 976
Yuejiao Zhong China 14 254 1.0× 153 0.8× 139 0.8× 130 0.8× 45 0.4× 32 576
Qinglian Wen China 18 284 1.1× 161 0.9× 172 1.0× 195 1.2× 47 0.4× 48 756
Luofu Wang China 19 355 1.4× 127 0.7× 109 0.6× 337 2.1× 99 0.9× 44 907
Hongjun Yuan China 15 220 0.9× 145 0.8× 117 0.6× 365 2.3× 75 0.7× 34 818
Marina Poettler Austria 11 203 0.8× 87 0.5× 140 0.8× 151 1.0× 40 0.4× 14 545

Countries citing papers authored by Jonathan S. Rink

Since Specialization
Citations

This map shows the geographic impact of Jonathan S. Rink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Rink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Rink more than expected).

Fields of papers citing papers by Jonathan S. Rink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Rink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Rink. The network helps show where Jonathan S. Rink may publish in the future.

Co-authorship network of co-authors of Jonathan S. Rink

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Rink. A scholar is included among the top collaborators of Jonathan S. Rink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Rink. Jonathan S. Rink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McMahon, Kaylin M., Andrea E. Calvert, Jonathan S. Rink, et al.. (2025). CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis. Proceedings of the National Academy of Sciences. 122(22). e2502876122–e2502876122. 2 indexed citations
2.
Rink, Jonathan S., Adam Yuh Lin, Andrea E. Calvert, et al.. (2024). Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1. ACS Applied Materials & Interfaces. 17(1). 363–373. 1 indexed citations
3.
Yang, Meiying, Jonathan S. Rink, Shuo Yang, et al.. (2022). Investigations of Redox Resistance in Aggressive Lymphomas with Cholesterol Modulating Lipid Nanoparticles. Blood. 140(Supplement 1). 5993–5994. 1 indexed citations
4.
Lin, Adam Yuh, Jonathan S. Rink, Yasmin Abaza, et al.. (2022). Synthetic Lipid Nanoparticles Actively Target Acute Myeloid Leukemia (AML) Cells and Induce Ferroptosis through Decreased Expression of Glutathione Peroxidase 4. Blood. 140(Supplement 1). 5967–5968. 2 indexed citations
5.
6.
Lin, Adam Yuh, Jonathan S. Rink, C. Shad Thaxton, & Leo I. Gordon. (2021). In Situ Vaccination with Combination of Class B and Class C Toll-like Receptor 9 Agonist CpG Immune Adjuvant Nanoparticles to Induce a Systemic Anti-Lymphoma Response. Blood. 138(Supplement 1). 2265–2265. 2 indexed citations
7.
Rink, Jonathan S., Adam Yuh Lin, Kaylin M. McMahon, et al.. (2020). Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. Journal of Biological Chemistry. 296. 100100–100100. 42 indexed citations
8.
Lin, Adam Yuh, Jonathan S. Rink, Reem Karmali, et al.. (2020). Tri-ethylene glycol modified class B and class C CpG conjugated gold nanoparticles for the treatment of lymphoma. Nanomedicine Nanotechnology Biology and Medicine. 30. 102290–102290. 6 indexed citations
9.
Singh, Abhalaxmi, Vikas Nandwana, Jonathan S. Rink, et al.. (2019). Biomimetic Magnetic Nanostructures: A Theranostic Platform Targeting Lipid Metabolism and Immune Response in Lymphoma. ACS Nano. 13(9). 10301–10311. 18 indexed citations
10.
Bell, Jonathan B., Jonathan S. Rink, Frank Eckerdt, et al.. (2018). HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma. Scientific Reports. 8(1). 1211–1211. 33 indexed citations
11.
Rink, Jonathan S., Wangqiang Sun, Sol Misener, et al.. (2018). Nitric Oxide-Delivering High-Density Lipoprotein-like Nanoparticles as a Biomimetic Nanotherapy for Vascular Diseases. ACS Applied Materials & Interfaces. 10(8). 6904–6916. 46 indexed citations
12.
Rink, Jonathan S., Shuo Yang, Osman Çen, et al.. (2018). Inhibition of Pro-Survival Pathways in DLBCL Cells By Functional Lipoprotein-like Nanoparticles. Blood. 132(Supplement 1). 1668–1668. 1 indexed citations
13.
Nandwana, Vikas, Soo‐Ryoon Ryoo, Kaylin M. McMahon, et al.. (2017). High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease. Chemistry of Materials. 29(5). 2276–2282. 42 indexed citations
14.
Rink, Jonathan S., et al.. (2017). Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. Physiological Reports. 5(4). e13128–e13128. 11 indexed citations
15.
Thaxton, C. Shad, Jonathan S. Rink, Pratap C. Naha, & David P. Cormode. (2016). Lipoproteins and lipoprotein mimetics for imaging and drug delivery. Advanced Drug Delivery Reviews. 106(Pt A). 116–131. 108 indexed citations
16.
Rink, Jonathan S., Shuo Yang, Osman Çen, et al.. (2015). Scavenger Receptor Type B1 Is Essential for High Density Lipoprotein Nanoparticle Induced B-Cell Lymphoma Cell Death. Blood. 126(23). 2756–2756. 1 indexed citations
17.
Rink, Jonathan S., Michael P. Plebanek, Sushant Tripathy, & C. Shad Thaxton. (2013). Update on current and potential nanoparticle cancer therapies. Current Opinion in Oncology. 25(6). 646–651. 38 indexed citations
18.
Rink, Jonathan S., Kaylin M. McMahon, Xiaomin Zhang, et al.. (2013). Knockdown of Intraislet IKKβ by Spherical Nucleic Acid Conjugates Prevents Cytokine-Induced Injury and Enhances Graft Survival. Transplantation. 96(10). 877–884. 6 indexed citations
19.
Rink, Jonathan S., Xiaojuan Chen, Xiaomin Zhang, & Dixon B. Kaufman. (2011). Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant. Surgery. 151(2). 330–339. 24 indexed citations
20.
Rink, Jonathan S., Kaylin M. McMahon, Xiaojuan Chen, et al.. (2010). Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles. Surgery. 148(2). 335–345. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bai Ji Breakdown of academic impact, for papers by Kaylin M. McMahon Breakdown of academic impact, for papers by Yuejiao Zhong Breakdown of academic impact, for papers by Qinglian Wen Breakdown of academic impact, for papers by Luofu Wang Breakdown of academic impact, for papers by Hongjun Yuan Breakdown of academic impact, for papers by Marina Poettler
Rankless by CCL
2026